Elizabeth A. Davis MD, FACS | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology ...
How should clinicians recognize Demodex blepharitis, and which specialists should be looking for it? These questions framed a recent Ophthalmology Times Clinical Forum in New Orleans, Louisiana: “ ...
Eleonora Lad, MD, PhD, Dimitra Skondra, MD, PhD, and John Kitchens, MD, point to structure and function, diet and the gut, ...
A study published in JAMA Ophthalmology 1 reported that spectacle lenses with highly aspherical lenslets (HAL) are safe and ...
Carey said the take-home message is “if you have a patient who’s had MS and optic neuritis, and they call your office saying, ...
The milestone moves what Oculis describes as the first genotype-guided registrational trial in DED a step closer to a readout ...
Prevent Blindness is observing its sixth annual Inflammatory Eye Disease (IED) Week from October 19 to 25, 2026, highlighting conjunctivitis and keratitis, thyroid eye disease (TED), and uveitis. 1 ...
CHMP backs Accord Healthcare’s Lucentis biosimilar Fovlussea for nAMD, DMO, RVO and CNV ahead of an EC decision. Fovlussea enters a European market where ranibizumab biosimilars have been commercially ...
Patients who say their eyes feel dry, gritty, or burning are among the most common in ophthalmology, and treating them well ...
The 2 complement inhibitors approved by the US Food and Drug Administration (FDA) for geographic atrophy (GA) secondary to ...
The FDA has approved Alcon’s apraclonidine ophthalmic solution 0.125% (Brytly), an over-the-counter eye drop for redness ...
SpyGlass Pharma has reported 4-year interim results from the first-in-human (FIH) trial of its Bimatoprost Drug Pad-IOL System (BIM-IOL System), extending what the company describes as the “longest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results